CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tabula Rasa HealthCare Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tabula Rasa HealthCare Inc
228 Strawbridge Drive
Phone: 866-648-2767p:866-648-2767 MOORESTOWN, NJ  08057  United States

This company was Merged or Acquired on 11/6/2023.
This company ceased filing statements with the SEC on 11/13/2023.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Tabula Rasa HealthCare, Inc. is a healthcare technology company. The Company operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
CEO and Chairman of the BOD Calvin H.Knowlton
Independent Chairman of the Board Michael J.Purcell 66 9/13/2022 7/18/2018
President and Director Orsula V.Knowlton
14 additional Officers and Directors records available in full report.

Business Names
Business Name
DM Acquisition Pty Ltd
DoseMe Holdings Pty Ltd
DoseMe Pty Ltd
5 additional Business Names available in full report.

General Information
Number of Employees: 1,027 (As of 12/31/2022)
Outstanding Shares: 27,054,536 (As of 7/28/2023)
Shareholders: 76
Stock Exchange: NASD
Federal Tax Id: 465726437
Email Address: info@trhc.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, November 5, 2024